Índice Bovespa

US Dollar vs BRL

Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.

Cadastre-se

Início
Investir
Ações
EUA
AMEX
Citigroup Fdg (CTH)
Citigroup Fdg (CTH) Notícias

CTH

Citigroup Fdg (CTH)

Citigroup Fdg

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:AMEX:CTH

1

Data	Hora	Fonte	Título	Código	Companhia
15/08/2016	07:00	GlobeNewswire	Cynapsus Announces Positive Opinion from Data and Safety Monitoring Board on Phase 3 Parkinson's Disease Clinical Study Allow...	AMEX:CTH	Citigroup Fdg
18/07/2016	17:10	GlobeNewswire	Cynapsus Therapeutics Announces Positive Phase 3 Dose Titration Phase Results with APL-130277 for the Treatment of OFF Episod...	AMEX:CTH	Citigroup Fdg
30/06/2016	09:00	GlobeNewswire	Cynapsus Therapeutics Enrolls Last Patient in Pivotal Phase 3 Efficacy Trial of APL-130277 to Treat OFF Episodes in Patients ...	AMEX:CTH	Citigroup Fdg
30/05/2016	03:00	GlobeNewswire	Cynapsus Therapeutics Announces Data Presentations at the European Academy of Neurology Annual Meeting	AMEX:CTH	Citigroup Fdg
15/04/2016	07:00	GlobeNewswire	Cynapsus Therapeutics Announces Data Presentations at the American Academy of Neurology Annual Meeting	AMEX:CTH	Citigroup Fdg
08/12/2015	05:00	GlobeNewswire	Cynapsus Therapeutics Announces Positive Data Presentations at World Congress on Parkinson's Disease and Related Disorders Me...	AMEX:CTH	Citigroup Fdg
17/07/2014	17:15	GlobeNewswire	Cynapsus Therapeutics Inc : Cynapsus Therapeutics Commences Phase 2 Clinical Trials in the United States	AMEX:CTH	Citigroup Fdg
08/07/2014	02:00	GlobeNewswire	Cynapsus Therapeutics Inc. : Cynapsus Therapeutics Awarded Second Grant from The Michael J. Fox Foundation for Parkinson's Re...	AMEX:CTH	Citigroup Fdg
14/05/2014	07:00	GlobeNewswire	Cynapsus Therapeutics Inc. : Cynapsus Announces No Buccal Mucosal Irritation in FDA Registration Study of APL-130277 for Park...	AMEX:CTH	Citigroup Fdg
24/04/2014	07:00	GlobeNewswire	Cynapsus Therapeutics Inc. : Cynapsus Announces Positive Results of CTH-104 Clinical Study of APL-130277 for Parkinson's Dise...	AMEX:CTH	Citigroup Fdg
28/03/2014	07:00	GlobeNewswire	Cynapsus Therapeutics Inc. : Cynapsus Announces Interim Summary Results of Human Healthy Volunteer Single 25mg Study for APL-...	AMEX:CTH	Citigroup Fdg
13/01/2014	09:00	GlobeNewswire	Cynapsus Therapeutics Inc. : Cynapsus Announces Completion of Human Healthy Volunteer Crossover Study Results for APL-130277	AMEX:CTH	Citigroup Fdg
15/05/2013	02:00	GlobeNewswire	Cynapsus Therapeutics Inc. : Cynapsus Therapeutics Publishes White Paper on Apomorphine for 'Off' Periods in Parkinson's Dise...	AMEX:CTH	Citigroup Fdg
24/03/2006	13:00	PR Newswire (US)	American Stock Exchange Lists Citigroup Funding Inc.'s 7.5% Sequins Linked to UnitedHealth Group Inc.	AMEX:CTH

Apresentando as notícias mais relevantes sobre:AMEX:CTH

1

Índice Bovespa

CM Hospitalar ON

Grupo Casas Bahia ON

$Logo da Infracommerce Caxaas ON (IFCM3).$

Infracommerce Caxaas ON

MAGAZINE LUIZA ON

PÃO DE AÇUCAR ON

HBR Realty Empreendiment... ON

Delayed Upgrade Clock

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições